Ketamine: What to know about the UK's growing drug problem
There is growing awareness of the problems caused by the use of a fast-acting drug called ketamine. Often referred to as K or ...
Radiopharmaceutical therapy offers promise for people with tough-to-treat meningioma brain tumors
A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine ...
People who experience side effects from cranial radiation therapy may recover full neurocognitive function within months
A substantial number of patients with brain metastases who experience cognitive side effects following radiation therapy may fully regain cognitive function, according to a pooled analysis of three ...
Access to a GP can make all the difference in surviving lung cancer—and that is a problem for Māori
Surviving lung cancer in Aotearoa New Zealand could depend on whether you can access a GP—raising questions about equity in ...
How alcohol-associated liver disease differs among races
Researchers have long known that outcomes for alcohol-associated liver disease (ALD) aren't equal among all races and ...
What is CAR-T cell therapy? Oncologist explains
Roughly 635,000 new cases of lymphoma were diagnosed worldwide, according to the World Cancer Research Fund International's ...
Shared reading starting in infancy promoted as a positive parenting practice with lifelong benefits
The American Academy of Pediatrics encourages parents and caregivers to read aloud with their newborns and young children as ...
Medical Xpress13d
Telemedicine improved doctors' quality of patient care during COVID, new research shows
We all remember when the COVID-19 lockdown in early 2020 upended the comfort of our daily routines. Businesses were forced to adapt to limited ways of engaging with customers, with varied levels ...
Medical Xpress11d
Bacterial infections could be trigger for type 1 diabetes, new research suggests
For the first time, scientists have found that proteins from bacteria can trigger the immune system to attack insulin-producing cells, leading to the development of type 1 diabetes. The new ...
Did COVID come from an animal market? Here's what the new evidence really tells us
The argument about the origins of COVID has always been heated, and nowadays it feels more like a brawl than a scientific ...
What pathogen might spark the next pandemic? How scientists are preparing for 'disease X'
Before the COVID pandemic, the World Health Organization (WHO) had made a list of priority infectious diseases. These were ...
Nations vow to cut deaths from drug resistant bacteria
World leaders meeting in New York have backed a new set of goals and pledged to find US$100 million in funding to address the ...